These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6311091)

  • 1. Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.
    Bastow KF; Derse DD; Cheng YC
    Antimicrob Agents Chemother; 1983 Jun; 23(6):914-7. PubMed ID: 6311091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Coen DM; Fleming HE; Leslie LK; Retondo MJ
    J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus mutants resistant to arabinosyladenine in the presence of deoxycoformycin.
    Fleming HE; Coen DM
    Antimicrob Agents Chemother; 1984 Sep; 26(3):382-7. PubMed ID: 6095755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
    Field H; McMillan A; Darby G
    J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined interaction of antiherpes substances and interferon beta on the multiplication of herpes simplex virus.
    Janz C; Wigand R
    Arch Virol; 1982; 73(2):135-43. PubMed ID: 6184033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
    Birch CJ; Tachedjian G; Doherty RR; Hayes K; Gust ID
    J Infect Dis; 1990 Sep; 162(3):731-4. PubMed ID: 2167340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.
    Gephart JF; Lerner AM
    Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
    Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of eight antiviral drugs on the reactivation of herpes simplex virus in explant cultures of latently infected mouse trigeminal ganglia.
    Klein RJ; Friedman-Kien AE
    J Invest Dermatol; 1984 Nov; 83(5):344-6. PubMed ID: 6208291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
    Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
    Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative studies of anti-herpes simplex virus compounds in vitro].
    Inoue S; Shiota H
    Nippon Ganka Gakkai Zasshi; 1982; 86(11):2113-21. PubMed ID: 6301237
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-Methoxymethyldeoxyuridine-resistant mutants of herpes simplex virus type 1.
    Veerisetty V; Gentry GA
    Virology; 1981 Oct; 114(2):576-9. PubMed ID: 6270889
    [No Abstract]   [Full Text] [Related]  

  • 13. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site.
    Hall JD; Wang YS; Pierpont J; Berlin MS; Rundlett SE; Woodward S
    Nucleic Acids Res; 1989 Nov; 17(22):9231-44. PubMed ID: 2555788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid.
    Derse D; Bastow KF; Cheng Y
    J Biol Chem; 1982 Sep; 257(17):10251-60. PubMed ID: 6286645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aphidicolin on DNA synthesis in HSV-1 infected and uninfected Vero cells.
    Larsson A; Wrååk M; Oberg B
    Antiviral Res; 1983 Aug; 3(2):87-91. PubMed ID: 6312879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates.
    Frank KB; Cheng YC
    Antimicrob Agents Chemother; 1985 Apr; 27(4):445-8. PubMed ID: 2988429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aphidicolin resistance in herpes simplex virus type 1 appears to alter substrate specificity in the DNA polymerase.
    Hall JD; Woodward S
    J Virol; 1989 Jun; 63(6):2874-6. PubMed ID: 2542598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel interaction of aphidicolin with herpes simplex virus DNA polymerase and polymerase-associated exonuclease.
    Frank KB; Derse DD; Bastow KF; Cheng YC
    J Biol Chem; 1984 Nov; 259(21):13282-6. PubMed ID: 6092371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and herpesvirus polymerases: their significance for chemotherapy.
    Müller WE; Falke D
    Adv Ophthalmol; 1979; 38():187-96. PubMed ID: 230715
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.
    Safrin S; Phan L
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2241-3. PubMed ID: 8257152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.